Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio.
This week, I am speaking with Greg Kubin, co-host of the Business Trip Podcast and co-founder and partner at PsyMed Ventures, a fund investing in frontier mental health technologies and treatments.
Greg and I chat pretty regularly, sometimes weekly, about the state of play in psychedelics, neurotech, investing, consciousness, and a rapidly changing world.
As an early-stage investor in frontier mental health and wellness technologies, Greg has a unique lens into what future approaches and landscapes might look like.
A recent focus in my writing has been the ‘emergent paradigms’ afoot that are nearing—or achieved—tipping points in their acceptance and application; in this conversation, Greg and I discuss a handful of these topics, including:
The Gut-Brain-Axis and the innovations afoot in diagnostics and precision pre & probiotics
Metabolic Health, its impact on mental health, and tools like the ketogenic diet
Neurotechnology and Brain-Computer Interface for diagnostics and therapeutics
We also discuss:
The origin story of PsyMed Ventures and the Business Trip Podcast
The pharmaceutical industrial complex
The relationship between academic research and commercialization and the archetype of the “Entrepreneurial Scientist.”
As well as many colorful tangents, digressions, and detours.
And now, I bring you my conversation with Greg Kubin.
Listen to the episode on Substack, Spotify, Google or Apple.
Credits:
Hosted by Zach Haigney
Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari
Find us at thetripreport.com
Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary
#16: Greg Kubin: The Varieties of Mental Health Innovation